Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy A Chan

Showing results (231-240 of 271) with videos related to

Pageof 28
Sort By:
Nature Genetics|January 5, 2021
The association between tumor mutational burden and prognosis is dependent on treatment contextCristina Valero, Mark Lee, Douglas Hoen, et al.
Cancer Research Communications|May 8, 2026
Novel Mechanism of and Therapeutic Approach for Anthracycline-Induced Cardiotoxicity (AIC)Qingzhu Wang, Wanying Zhang, Josephine Chen, et al.
Nature Cancer|April 9, 2021
Mutations in <i>BRCA1</i> and <i>BRCA2</i> differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapyRobert M Samstein, Chirag Krishna, Xiaoxiao Ma, et al.
JAMA Oncology|July 22, 2016
The Molecular Landscape of Recurrent and Metastatic Head and Neck Cancers: Insights From a Precision Oncology Sequencing PlatformLuc G T Morris, Raghu Chandramohan, Lyndsay West, et al.
The Journal of Clinical Endocrinology and Metabolism|December 25, 2012
Exomic sequencing of medullary thyroid cancer reveals dominant and mutually exclusive oncogenic mutations in RET and RASNishant Agrawal, Yuchen Jiao, Mark Sausen, et al.
JCI Insight|May 30, 2023
The MIF promoter SNP rs755622 is associated with immune activation in glioblastomaTyler J Alban, Matthew M Grabowski, Balint Otvos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 6, 2026
Radiation Oncology-Biology Integration Network (ROBIN): Bridging the gap between biological research and clinical practiceFabiana Gregucci, Christine Lee-Poturalski, Madelyn Dirrim, et al.
Nature Medicine|August 24, 2023
Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trialJoris L Vos, Bharat Burman, Swati Jain, et al.
Nature Cancer|May 9, 2025
Impaired T cell and neoantigen retention in time-serial analysis of metastatic non-small cell lung cancer in patients unresponsive to TIL cell therapyChao Wang, Xiaoqing Yu, Jamie K Teer, et al.
The Journal of Clinical Investigation|September 5, 2019
Genetic hallmarks of recurrent/metastatic adenoid cystic carcinomaAllen S Ho, Angelica Ochoa, Gowtham Jayakumaran, et al.
Pageof 28

Showing results (231-240 of 271) with videos related to

Sort By:
Pageof 28
Nature Genetics|January 5, 2021
The association between tumor mutational burden and prognosis is dependent on treatment contextCristina Valero, Mark Lee, Douglas Hoen, et al.
Cancer Research Communications|May 8, 2026
Novel Mechanism of and Therapeutic Approach for Anthracycline-Induced Cardiotoxicity (AIC)Qingzhu Wang, Wanying Zhang, Josephine Chen, et al.
Nature Cancer|April 9, 2021
Mutations in <i>BRCA1</i> and <i>BRCA2</i> differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapyRobert M Samstein, Chirag Krishna, Xiaoxiao Ma, et al.
JAMA Oncology|July 22, 2016
The Molecular Landscape of Recurrent and Metastatic Head and Neck Cancers: Insights From a Precision Oncology Sequencing PlatformLuc G T Morris, Raghu Chandramohan, Lyndsay West, et al.
The Journal of Clinical Endocrinology and Metabolism|December 25, 2012
Exomic sequencing of medullary thyroid cancer reveals dominant and mutually exclusive oncogenic mutations in RET and RASNishant Agrawal, Yuchen Jiao, Mark Sausen, et al.
JCI Insight|May 30, 2023
The MIF promoter SNP rs755622 is associated with immune activation in glioblastomaTyler J Alban, Matthew M Grabowski, Balint Otvos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 6, 2026
Radiation Oncology-Biology Integration Network (ROBIN): Bridging the gap between biological research and clinical practiceFabiana Gregucci, Christine Lee-Poturalski, Madelyn Dirrim, et al.
Nature Medicine|August 24, 2023
Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trialJoris L Vos, Bharat Burman, Swati Jain, et al.
Nature Cancer|May 9, 2025
Impaired T cell and neoantigen retention in time-serial analysis of metastatic non-small cell lung cancer in patients unresponsive to TIL cell therapyChao Wang, Xiaoqing Yu, Jamie K Teer, et al.
The Journal of Clinical Investigation|September 5, 2019
Genetic hallmarks of recurrent/metastatic adenoid cystic carcinomaAllen S Ho, Angelica Ochoa, Gowtham Jayakumaran, et al.
Pageof 28